Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 29, 2019

SELL
$90.66 - $116.63 $205,798 - $264,750
-2,270 Closed
0 $0
Q3 2018

Oct 17, 2018

SELL
$89.96 - $114.58 $119,107 - $151,703
-1,324 Reduced 36.84%
2,270 $260,000
Q2 2018

Jul 23, 2018

SELL
$71.53 - $95.75 $6,080 - $8,138
-85 Reduced 2.31%
3,594 $322,000
Q1 2018

Apr 23, 2018

BUY
$60.72 - $74.41 $223,388 - $273,754
3,679 New
3,679 $269,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.26B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.